BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) major shareholder Saba Capital Management, L.P. sold 44,884 shares of the company’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $16.48, for a total transaction of $739,688.32. Following the completion of the sale, the insider now directly owns 16,114,773 shares of the company’s stock, valued at $265,571,459.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Saba Capital Management, L.P. also recently made the following trade(s):
- On Wednesday, September 25th, Saba Capital Management, L.P. sold 8,800 shares of BlackRock Capital Allocation Term Trust stock. The shares were sold at an average price of $16.44, for a total transaction of $144,672.00.
- On Monday, September 23rd, Saba Capital Management, L.P. sold 33,209 shares of BlackRock Capital Allocation Term Trust stock. The shares were sold at an average price of $16.44, for a total transaction of $545,955.96.
- On Thursday, September 19th, Saba Capital Management, L.P. sold 14,973 shares of BlackRock Capital Allocation Term Trust stock. The shares were sold at an average price of $16.41, for a total transaction of $245,706.93.
- On Tuesday, September 17th, Saba Capital Management, L.P. sold 15,894 shares of BlackRock Capital Allocation Term Trust stock. The stock was sold at an average price of $16.41, for a total transaction of $260,820.54.
BlackRock Capital Allocation Term Trust Trading Up 0.1 %
NYSE BCAT traded up $0.01 during trading hours on Tuesday, hitting $16.46. 139,697 shares of the stock were exchanged, compared to its average volume of 351,158. BlackRock Capital Allocation Term Trust has a 12-month low of $13.67 and a 12-month high of $17.18. The stock has a 50-day moving average of $16.29 and a 200 day moving average of $16.23.
BlackRock Capital Allocation Term Trust Increases Dividend
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the company. Eagle Rock Investment Company LLC acquired a new position in BlackRock Capital Allocation Term Trust during the first quarter worth about $298,000. Truist Financial Corp acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $319,000. Virtu Financial LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the fourth quarter valued at approximately $315,000. Karpus Management Inc. grew its position in shares of BlackRock Capital Allocation Term Trust by 19.6% in the fourth quarter. Karpus Management Inc. now owns 26,600 shares of the company’s stock valued at $398,000 after purchasing an additional 4,350 shares during the last quarter. Finally, Ironsides Asset Advisors LLC grew its position in shares of BlackRock Capital Allocation Term Trust by 14.1% in the first quarter. Ironsides Asset Advisors LLC now owns 29,133 shares of the company’s stock valued at $485,000 after purchasing an additional 3,606 shares during the last quarter. 36.12% of the stock is owned by hedge funds and other institutional investors.
About BlackRock Capital Allocation Term Trust
–
Recommended Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Lennar Stock Could Be the Best Play in the Housing Market
- P/E Ratio Calculation: How to Assess Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- About the Markup Calculator
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.